Deletion 5q in myelodysplastic syndrome: a paradigm for the study of hemizygous deletions in cancer (Q37423777)

20 August 2017

1 reference

title

Deletion 5q in myelodysplastic syndrome: a paradigm for the study of hemizygous deletions in cancer (English)

1 reference

20 August 2017

main subject

myelodysplastic syndrome

1 reference

B L Ebert

1 reference

20 August 2017

publication date

26 March 2009

1 reference

20 August 2017

1 reference

20 August 2017

1 reference

20 August 2017

1 reference

20 August 2017

page(s)

1252-1256

1 reference

Mutation and cancer: statistical study of retinoblastoma

20 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2009.53

Inherited susceptibility to common cancers

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2009.53

Cancer biology. A matter of dosage

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2009.53

Specific inhibition of gene expression by small double-stranded RNAs in invertebrate and vertebrate systems

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2009.53

Duplexes of 21-nucleotide RNAs mediate RNA interference in cultured mammalian cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2009.53

A lentiviral RNAi library for human and mouse genes applied to an arrayed viral high-content screen

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2009.53

A lentivirus-based system to functionally silence genes in primary mammalian cells, stem cells and transgenic mice by RNA interference

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2009.53

Distinct haematological disorder with deletion of long arm of no. 5 chromosome

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2009.53

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2009.53

Macrocytic anemia, thrombocytosis and nonlobulated megakaryocytes: the 5q-syndrome, a distinct entity

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2009.53

Clinical management of myelodysplastic syndromes with interstitial deletion of chromosome 5q.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2009.53

The World Health Organization (WHO) classification of the myeloid neoplasms

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2009.53

Evidence for the involvement of GM-CSF and FMS in the deletion (5q) in myeloid disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2009.53

Deletion of IRF-1, mapping to chromosome 5q31.1, in human leukemia and preleukemic myelodysplasia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2009.53

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2009.53

Molecular cytogenetic delineation of the critical deleted region in the 5q- syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2009.53

Molecular delineation of the smallest commonly deleted region of chromosome 5 in malignant myeloid diseases to 1-1.5 Mb and preparation of a PAC-based physical map.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2009.53

A tyrosine kinase created by fusion of the PDGFRA and FIP1L1 genes as a therapeutic target of imatinib in idiopathic hypereosinophilic syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2009.53

Fusion of PDGF receptor beta to a novel ets-like gene, tel, in chronic myelomonocytic leukemia with t(5;12) chromosomal translocation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2009.53

Genome-wide analysis of genetic alterations in acute lymphoblastic leukaemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2009.53

Haploinsufficiency of CBFA2 causes familial thrombocytopenia with propensity to develop acute myelogenous leukaemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2009.53

Identification of RPS14 as a 5q- syndrome gene by RNA interference screen

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2009.53

Mutation of ribosomal protein RPS24 in Diamond-Blackfan anemia results in a ribosome biogenesis disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2009.53

Ribosomal protein S17 gene (RPS17) is mutated in Diamond-Blackfan anemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2009.53

The gene encoding ribosomal protein S19 is mutated in Diamond-Blackfan anaemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2009.53

Ribosomal protein S24 gene is mutated in Diamond-Blackfan anemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2009.53

Impaired ribosome biogenesis in Diamond-Blackfan anemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2009.53

Human RPS19, the gene mutated in Diamond-Blackfan anemia, encodes a ribosomal protein required for the maturation of 40S ribosomal subunits

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2009.53

Abnormalities of the large ribosomal subunit protein, Rpl35a, in Diamond-Blackfan anemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2009.53

Ribosomes and marrow failure: coincidental association or molecular paradigm?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2009.53

Ribosomal mutations cause p53-mediated dark skin and pleiotropic effects

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2009.53

Deficiency of ribosomal protein S19 during early embryogenesis leads to reduction of erythrocytes in a zebrafish model of Diamond-Blackfan anemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2009.53

Many ribosomal protein genes are cancer genes in zebrafish

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2009.53

Chromosome 5q deletion and epigenetic suppression of the gene encoding alpha-catenin (CTNNA1) in myeloid cell transformation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2009.53

An erythroid differentiation signature predicts response to lenalidomide in myelodysplastic syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2009.53

Lenalidomide inhibits the malignant clone and up-regulates the SPARC gene mapping to the commonly deleted region in 5q- syndrome patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2009.53

Common deleted genes in the 5q- syndrome: thrombocytopenia and reduced erythroid colony formation in SPARC null mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2009.53

Haploinsufficiency of EGR1, a candidate gene in the del(5q), leads to the development of myeloid disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2009.53

The transcription factor EGR1 controls both the proliferation and localization of hematopoietic stem cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2009.53

Cytoplasmic nucleophosmin in acute myelogenous leukemia with a normal karyotype

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2009.53

Role of nucleophosmin in embryonic development and tumorigenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2009.53

21 January 2018

Nucleophosmin and cancer

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2009.53

Npm1 is a haploinsufficient suppressor of myeloid and lymphoid malignancies in the mouse

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2009.53

Lack of RPS14 promoter aberrant methylation supports the haploinsufficiency model for the 5q- syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2009.53

Hematological features of patients with myelodysplastic syndromes associated with a chromosome 5q deletion

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2009.53

7 January 2021

Myelodysplastic syndromes associated with interstitial deletion of chromosome 5q: clinicopathologic correlations and new insights from the pre-lenalidomide era

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2009.53

7 January 2021

New insights into the prognostic impact of the karyotype in MDS and correlation with subtypes: evidence from a core dataset of 2124 patients

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2009.53

7 January 2021

Molecular Mapping of Uncharacteristically Small 5q Deletions in Two Patients with the 5q- Syndrome: Delineation of the Critical Region on 5q and Identification of a 5q- Breakpoint

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2009.53

7 January 2021

Narrowing and genomic annotation of the commonly deleted region of the 5q- syndrome

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2009.53

7 January 2021

Gene expression profiling of CD34+cells in patients with the 5q− syndrome

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2009.53

7 January 2021

Mutation analysis of the SPARC gene in the 5q-syndrome

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2009.53

7 January 2021

Identifiers

DOI

10.1038/LEU.2009.53

1 reference

20 August 2017

1 reference